(19)
(11) EP 4 004 240 A1

(12)

(43) Date of publication:
01.06.2022 Bulletin 2022/22

(21) Application number: 20746610.3

(22) Date of filing: 24.07.2020
(51) International Patent Classification (IPC): 
C12Q 1/70(2006.01)
(52) Cooperative Patent Classification (CPC):
C12Q 1/701; C12Q 2600/16; C12Q 1/70
 
C-Sets:
C12Q 1/70, C12Q 2531/113, C12Q 2561/101;
(86) International application number:
PCT/EP2020/070896
(87) International publication number:
WO 2021/013972 (28.01.2021 Gazette 2021/04)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 25.07.2019 US 201962878643 P

(71) Applicants:
  • F. Hoffmann-La Roche AG
    4070 Basel (CH)

    AL AT BE BG CH CY CZ DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR 
  • Roche Diagnostics GmbH
    68305 Mannheim (DE)

    DE 

(72) Inventors:
  • HAMILTON, Aaron T.
    Pleasanton, California 94588 (US)
  • HEIL, Marintha
    Pleasanton, California 94588 (US)
  • LIGGETT, Debra
    Pleasanton, California 94588 (US)
  • SUN, Jingtao
    Pleasanton, California 94588 (US)
  • WANG, Ling
    Pleasanton, California 94588 (US)
  • WU, Xiaoning
    Pleasanton, California 94588 (US)

(74) Representative: Hövelmann, Sascha Alexander 
Roche Diagnostics GmbH Patent Department (LPMM.....6164) Sandhofer Straße 116
68305 Mannheim
68305 Mannheim (DE)

   


(54) COMPOSITIONS AND METHODS FOR DETECTION OF EPSTEIN BARR VIRUS (EBV)